CeriBell, Inc.
CBLLNASDAQHealthcareMedical Devices

About CeriBell

CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Company Information

CEOXingjuan Chao
Founded2014
IPO DateOctober 11, 2024
Employees281
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone800 436 0826
Address
360 North Pastoria Avenue Sunnyvale, California 94085 United States

Corporate Identifiers

CIK0001861107
CUSIP15678C102
ISINUS15678C1027
EIN47-1785452
SIC3845

Leadership Team & Key Executives

Dr. Xingjuan Chao Ph.D.
Co-Founder, President, Chief Executive Officer and Director
Dr. Josef Parvizi M.D., Ph.D.
Co-Founder, Chief Medical Advisor and Director
Scott Blumberg
Chief Financial Officer
Dr. Raymond Woo Ph.D.
Chief Technology Officer
Dan Rogy
Senior Vice President of Operations
Louisa Daniels J.D., M.B.A.
General Counsel
Brian P. Price
Senior Vice President of Marketing
Kim McKeon
Vice President of People and Culture
Baharan Kamousi Ph.D.
Senior Vice President of Data Science
Sean Manni
Chief Revenue Officer